DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Pfizer (NYSE: PFE)

35.27 -0.09 (-0.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $35.27 -0.25%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.20
Previous Close $35.36
Daily Range $35.05 - $35.40
52-Week Range $27.51 - $35.53
Market Cap $216.2B
P/E Ratio 25.08
Dividend (Yield) $1.12 (3.2%)
Ex-Dividend Date
Dividend Pay Date
05/06/15
06/02/15
Volume 22,801,317
Average Daily Volume 27,040,205
Current FY EPS $2.07

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

Big Pharma Comes Under Attack From a New Hedge Fund Strategy

Just in case you thought Big Pharma didn't have enough to worry about, this new hedge fund strategy could bring select Big Pharma companies to their knees.

Apple & Other Earnings Expected To Dominate The Week Of April 27

7 DIJA Earnings Previews for This Week: Apple, Merck, Pfizer, Exxon, Visa, Chevron

Astra Deals Add To Ballooning Up-Front Payments

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

The Parade of Weak Earnings Reports Continues - Earnings Preview

After Hours Most Active for Apr 24, 2015 : CLF, QQQ, NRP, PFE, VALE, SBUX, LGCY, AAPL, ORCL, ETE, M

After Hours Most Active for Apr 24, 2015 : CLF, QQQ, NRP, PFE, VALE, SBUX, LGCY, AAPL, ORCL, ETE, MSFT, CSALV

Dogs Of The Dow March Quarter Roundup

Nurturing Your Portfolio With Mead Johnson

Pfizer's Once And Future Deals

See More PFE News...

PFE's Top Competitors

PFE $35.27 (-0.25%)
Current stock: PFE
JNJ $101.08 (0.62%)
Current stock: JNJ
ROG $79.96 (-0.58%)
Current stock: ROG
GSK $46.59 (0.60%)
Current stock: GSK